Compare ADMA Biologics Inc (ADMA) vs Matson Inc (MATX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs Matson Inc — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Matson Inc trades at $204.7 (market cap $6.11B). The key difference: Matson Inc is far larger — about 2.8× ADMA Biologics Inc's market cap, and Matson Inc pays a 0.74% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | MATX | |
|---|---|---|
Market Cap | $2.22B | $6.11B |
Sector | Health | Technology |
52-Week High | $20.38 | $223.55 |
52-Week Low | $7.60 | $88.05 |
Enterprise Value | $2.29B | $6.71B |
Dividend Yield | — | 0.74% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Matson Inc
Matson, Inc. is an American shipping and logistics company primarily operating in the Pacific. The company provides ocean transportation services, including container, automobile, and general cargo, particularly between the U.S. West Coast, Hawaii, Alaska, and Guam. Matson also offers logistics services, including warehousing, less-than-container load (LCL) consolidation, and supply chain management, making it a critical service provider for businesses operating across the Pacific region.
Read more on MATX →
